Texas 2009 81st Regular

Texas House Bill HB3067 Introduced / Bill

Filed 02/01/2025

Download
.pdf .doc .html
                    81R2059 JAM-F
 By: Hopson H.B. No. 3067


 A BILL TO BE ENTITLED
 AN ACT
 relating to the confidentiality of test results of samples of
 compounded products.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1. Section 556.053, Occupations Code, is amended to
 read as follows:
 Sec. 556.053. EXTENT OF INSPECTION; CONFIDENTIALITY. (a)
 Except as otherwise provided in an inspection warrant, the person
 authorized to represent the board may:
 (1) inspect and copy documents, including records or
 reports, required to be kept or made under this subtitle, Chapter
 481 or 483, Health and Safety Code, or the Comprehensive Drug Abuse
 Prevention and Control Act of 1970 (21 U.S.C. Section 801 et seq.)
 or rules adopted under one of those laws;
 (2) inspect, within reasonable limits and in a
 reasonable manner, a facility's storage, equipment, security,
 prescription drugs or devices, components used in compounding,
 finished and unfinished products, or records; or
 (3) perform an inventory of any stock of prescription
 drugs or devices, components used in compounding, or finished and
 unfinished products in a facility and obtain samples of those
 substances.
 (b)  Reports, records, formulas, and test results of samples
 of products compounded by pharmacies obtained by the board are
 confidential and do not constitute public information for purposes
 of Chapter 552, Government Code. The board may create, use, or
 disclose statistical information from the test results of samples
 of compounded products.
 SECTION 2. This Act takes effect immediately if it receives
 a vote of two-thirds of all the members elected to each house, as
 provided by Section 39, Article III, Texas Constitution. If this
 Act does not receive the vote necessary for immediate effect, this
 Act takes effect September 1, 2009.